Cell culture screening and process development programs have long been hampered by limited scalability of shaken cultures and capacity bottlenecks in benchtop bioreactor studies. The situation has changed in recent years with industry wide adoption of the ambr™ high throughput micro bioreactor system. In this brief webinar, industry data shows how ambr can improve scalability, open bottlenecks and apply bioreactor DoE to transform cell line development workflows.